209 related articles for article (PubMed ID: 10940236)
21. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
22. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ
Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783
[TBL] [Abstract][Full Text] [Related]
23. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR.
Wong E; Thackray AM; Bujdoso R
Biochem J; 2004 May; 380(Pt 1):273-82. PubMed ID: 14969585
[TBL] [Abstract][Full Text] [Related]
24. Properties of scrapie prion protein liposomes.
Gabizon R; McKinley MP; Groth DF; Kenaga L; Prusiner SB
J Biol Chem; 1988 Apr; 263(10):4950-5. PubMed ID: 3350818
[TBL] [Abstract][Full Text] [Related]
25. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
[TBL] [Abstract][Full Text] [Related]
26. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
[TBL] [Abstract][Full Text] [Related]
27. Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction.
Inouye H; Kirschner DA
J Struct Biol; 1998; 122(1-2):247-55. PubMed ID: 9724626
[TBL] [Abstract][Full Text] [Related]
28. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
29. Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity.
Riesner D; Kellings K; Post K; Wille H; Serban H; Groth D; Baldwin MA; Prusiner SB
J Virol; 1996 Mar; 70(3):1714-22. PubMed ID: 8627692
[TBL] [Abstract][Full Text] [Related]
30. Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation.
Breydo L; Bocharova OV; Makarava N; Salnikov VV; Anderson M; Baskakov IV
Biochemistry; 2005 Nov; 44(47):15534-43. PubMed ID: 16300402
[TBL] [Abstract][Full Text] [Related]
31. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T
J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242
[TBL] [Abstract][Full Text] [Related]
32. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin and congo red effectiveness on prion infectivity in golden Syrian hamster.
Corato M; Ogliari P; Ceciliani F; Cova E; Bellotti V; Cereda C; Merlini G; Ceroni M
Anticancer Res; 2009 Jul; 29(7):2507-12. PubMed ID: 19596920
[TBL] [Abstract][Full Text] [Related]
34. Detection of prion particles in samples of BSE and scrapie by fluorescence correlation spectroscopy without proteinase K digestion.
Birkmann E; Schäfer O; Weinmann N; Dumpitak C; Beekes M; Jackman R; Thorne L; Riesner D
Biol Chem; 2006 Jan; 387(1):95-102. PubMed ID: 16497169
[TBL] [Abstract][Full Text] [Related]
35. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
[TBL] [Abstract][Full Text] [Related]
36. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
37. Chaperonin-mediated de novo generation of prion protein aggregates.
Stöckel J; Hartl FU
J Mol Biol; 2001 Nov; 313(4):861-72. PubMed ID: 11697909
[TBL] [Abstract][Full Text] [Related]
38. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
[TBL] [Abstract][Full Text] [Related]
39. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.
Lee S; Eisenberg D
Nat Struct Biol; 2003 Sep; 10(9):725-30. PubMed ID: 12897768
[TBL] [Abstract][Full Text] [Related]
40. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
Enari M; Flechsig E; Weissmann C
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]